US Stock MarketDetailed Quotes

Rigel Pharmaceuticals (RIGL)

Watchlist
  • 30.290
  • -0.430-1.40%
Close Apr 24 16:00 ET
  • 30.290
  • 0.0000.00%
Post 20:01 ET
559.76MMarket Cap1.55P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rigel Pharmaceuticals (RIGL) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
140.40%75.66M
51.55%21.98M
10.85%24.03M
10,011.59%30.54M
82.19%-893K
647.99%31.47M
332.42%14.5M
1,695.22%21.68M
-94.91%302K
-23.05%-5.01M
Net income from continuing operations
1,999.08%367.02M
1,769.22%268.07M
124.62%27.9M
5,887.67%59.61M
238.79%11.45M
169.69%17.49M
1,845.86%14.34M
318.22%12.42M
84.39%-1.03M
39.07%-8.25M
Operating gains losses
----
----
----
----
----
-129.70%-79K
49.09%-56K
----
----
----
Depreciation and amortization
8.39%2.42M
-0.50%601K
-1.31%603K
-0.98%607K
51.00%604K
79.97%2.23M
106.14%604K
109.25%611K
107.09%613K
12.04%400K
Deferred tax
---245.85M
----
----
----
----
--0
----
----
----
----
Other non cash items
---39.98M
--0
--0
----
----
----
----
----
----
----
Change In working capital
-12,852.94%-19.51M
-51.98%-3.34M
-220.89%-7.37M
540.73%7.27M
-667.40%-16.08M
-98.39%153K
75.13%-2.2M
173.93%6.1M
-116.41%-1.65M
-134.53%-2.1M
-Change in receivables
8.29%-10.15M
47.12%-5.84M
-260.14%-6.02M
217.82%1.64M
-97.76%68K
-213.25%-11.07M
-57.62%-11.04M
38.72%-1.67M
-116.29%-1.39M
-72.27%3.04M
-Change in inventory
-837.57%-5.64M
-41.25%1.13M
-94.38%188K
-281.18%-8.37M
161.17%1.41M
-34.81%764K
-23.94%1.93M
1,090.04%3.34M
-810.36%-2.2M
-18.52%-2.31M
-Change in prepaid assets
-244.42%-11.85M
-7,797.73%-3.39M
-34.10%-1.87M
1,222.78%6.56M
-408.90%-13.15M
-267.48%-3.44M
101.34%44K
-172.03%-1.4M
-83.46%496K
-759.18%-2.58M
-Change in payables and accrued expense
263.52%5.3M
220.69%5.51M
-474.84%-2.4M
282.49%3.96M
-161.92%-1.76M
28.90%-3.24M
-177.66%-4.56M
-76.33%640K
3.64%-2.17M
184.54%2.85M
-Change in other current assets
-209.59%-674K
-18.24%130K
-17.42%128K
-16.45%127K
-810.74%-1.06M
-42.47%615K
8.16%159K
1,509.09%155K
442.86%152K
-83.54%149K
-Change in other current liabilities
-89.80%439K
-108.85%-426K
53.18%-81K
47.65%-89K
716.07%1.04M
228.99%4.3M
462.77%4.81M
92.04%-173K
27.35%-170K
-142.21%-168K
-Change in other working capital
-75.03%3.05M
-107.04%-455K
-48.31%2.69M
-5.21%3.44M
14.63%-2.62M
264.86%12.22M
271.86%6.46M
134.79%5.2M
449.85%3.63M
-143.19%-3.07M
Cash from discontinued investing activities
Operating cash flow
140.40%75.66M
51.55%21.98M
10.85%24.03M
10,011.59%30.54M
82.19%-893K
647.99%31.47M
332.42%14.5M
1,695.22%21.68M
-94.91%302K
-23.05%-5.01M
Investing cash flow
Cash flow from continuing investing activities
-2,336.44%-92.37M
-132.38%-25.36M
-972.57%-33.18M
-312.97%-23.28M
-3,471.25%-10.55M
196.11%4.13M
-58.77%-10.91M
424.96%3.8M
267.98%10.93M
-59.72%313K
Capital expenditure reported
--0
146.15%12K
----
----
----
---36K
---26K
----
----
----
Net PPE purchase and sale
--0
--0
----
----
----
-62.16%98K
-34.55%72K
18.18%26K
--0
--0
Net intangibles purchase and sale
--0
--0
--0
--0
--0
97.60%-360K
--0
--0
---222K
99.08%-138K
Net investment purchase and sale
-2,185.93%-92.37M
-131.51%-25.37M
-975.94%-33.16M
-308.73%-23.28M
-2,439.69%-10.55M
-57.60%4.43M
-56.93%-10.96M
417.62%3.79M
275.45%11.15M
-97.12%451K
Cash from discontinued investing activities
Investing cash flow
-2,336.44%-92.37M
-132.38%-25.36M
-972.57%-33.18M
-312.97%-23.28M
-3,471.25%-10.55M
196.11%4.13M
-58.77%-10.91M
424.96%3.8M
267.98%10.93M
-59.72%313K
Financing cash flow
Cash flow from continuing financing activities
105.16%601K
-412.08%-4.57M
143.40%4.27M
155.59%418K
119.27%484K
-163.38%-11.64M
201.44%1.47M
-1,032.57%-9.84M
-101.61%-752K
-113.14%-2.51M
Net issuance payments of debt
---7.5M
----
----
----
----
--0
--0
--0
--0
--0
Net common stock issuance
--0
----
----
----
----
---10M
----
----
----
----
Proceeds from stock option exercised by employees
312.47%8.1M
99.86%2.93M
2,603.16%4.27M
65.87%418K
443.82%484K
87.23%1.96M
201.44%1.47M
1,655.56%158K
-54.43%252K
8,800.00%89K
Net other financing activities
----
----
----
----
----
-36.97%-3.61M
--10M
-1,038.95%-10M
-8.42%-1M
-214.13%-2.6M
Cash from discontinued financing activities
Financing cash flow
105.16%601K
-412.08%-4.57M
143.40%4.27M
155.59%418K
119.27%484K
-163.38%-11.64M
201.44%1.47M
-1,032.57%-9.84M
-101.61%-752K
-113.14%-2.51M
Net cash flow
Beginning cash position
73.08%56.75M
-6.00%48.59M
48.29%53.46M
79.03%45.79M
73.08%56.75M
34.04%32.79M
13.82%51.69M
-26.14%36.05M
-36.52%25.57M
34.04%32.79M
Current changes in cash
-167.23%-16.11M
-257.38%-7.95M
-131.16%-4.87M
-26.72%7.68M
-51.98%-10.96M
187.74%23.96M
140.02%5.05M
560.24%15.64M
22.89%10.48M
-145.57%-7.21M
End cash Position
-28.39%40.64M
-28.39%40.64M
-6.00%48.59M
48.29%53.46M
79.03%45.79M
73.08%56.75M
73.08%56.75M
13.82%51.69M
-26.14%36.05M
-36.52%25.57M
Free cash flow
143.46%75.66M
51.91%21.99M
10.84%24.02M
38,071.25%30.54M
82.66%-893K
249.81%31.08M
332.00%14.48M
1,694.48%21.67M
-98.65%80K
72.99%-5.15M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 140.40%75.66M51.55%21.98M10.85%24.03M10,011.59%30.54M82.19%-893K647.99%31.47M332.42%14.5M1,695.22%21.68M-94.91%302K-23.05%-5.01M
Net income from continuing operations 1,999.08%367.02M1,769.22%268.07M124.62%27.9M5,887.67%59.61M238.79%11.45M169.69%17.49M1,845.86%14.34M318.22%12.42M84.39%-1.03M39.07%-8.25M
Operating gains losses ---------------------129.70%-79K49.09%-56K------------
Depreciation and amortization 8.39%2.42M-0.50%601K-1.31%603K-0.98%607K51.00%604K79.97%2.23M106.14%604K109.25%611K107.09%613K12.04%400K
Deferred tax ---245.85M------------------0----------------
Other non cash items ---39.98M--0--0----------------------------
Change In working capital -12,852.94%-19.51M-51.98%-3.34M-220.89%-7.37M540.73%7.27M-667.40%-16.08M-98.39%153K75.13%-2.2M173.93%6.1M-116.41%-1.65M-134.53%-2.1M
-Change in receivables 8.29%-10.15M47.12%-5.84M-260.14%-6.02M217.82%1.64M-97.76%68K-213.25%-11.07M-57.62%-11.04M38.72%-1.67M-116.29%-1.39M-72.27%3.04M
-Change in inventory -837.57%-5.64M-41.25%1.13M-94.38%188K-281.18%-8.37M161.17%1.41M-34.81%764K-23.94%1.93M1,090.04%3.34M-810.36%-2.2M-18.52%-2.31M
-Change in prepaid assets -244.42%-11.85M-7,797.73%-3.39M-34.10%-1.87M1,222.78%6.56M-408.90%-13.15M-267.48%-3.44M101.34%44K-172.03%-1.4M-83.46%496K-759.18%-2.58M
-Change in payables and accrued expense 263.52%5.3M220.69%5.51M-474.84%-2.4M282.49%3.96M-161.92%-1.76M28.90%-3.24M-177.66%-4.56M-76.33%640K3.64%-2.17M184.54%2.85M
-Change in other current assets -209.59%-674K-18.24%130K-17.42%128K-16.45%127K-810.74%-1.06M-42.47%615K8.16%159K1,509.09%155K442.86%152K-83.54%149K
-Change in other current liabilities -89.80%439K-108.85%-426K53.18%-81K47.65%-89K716.07%1.04M228.99%4.3M462.77%4.81M92.04%-173K27.35%-170K-142.21%-168K
-Change in other working capital -75.03%3.05M-107.04%-455K-48.31%2.69M-5.21%3.44M14.63%-2.62M264.86%12.22M271.86%6.46M134.79%5.2M449.85%3.63M-143.19%-3.07M
Cash from discontinued investing activities
Operating cash flow 140.40%75.66M51.55%21.98M10.85%24.03M10,011.59%30.54M82.19%-893K647.99%31.47M332.42%14.5M1,695.22%21.68M-94.91%302K-23.05%-5.01M
Investing cash flow
Cash flow from continuing investing activities -2,336.44%-92.37M-132.38%-25.36M-972.57%-33.18M-312.97%-23.28M-3,471.25%-10.55M196.11%4.13M-58.77%-10.91M424.96%3.8M267.98%10.93M-59.72%313K
Capital expenditure reported --0146.15%12K---------------36K---26K------------
Net PPE purchase and sale --0--0-------------62.16%98K-34.55%72K18.18%26K--0--0
Net intangibles purchase and sale --0--0--0--0--097.60%-360K--0--0---222K99.08%-138K
Net investment purchase and sale -2,185.93%-92.37M-131.51%-25.37M-975.94%-33.16M-308.73%-23.28M-2,439.69%-10.55M-57.60%4.43M-56.93%-10.96M417.62%3.79M275.45%11.15M-97.12%451K
Cash from discontinued investing activities
Investing cash flow -2,336.44%-92.37M-132.38%-25.36M-972.57%-33.18M-312.97%-23.28M-3,471.25%-10.55M196.11%4.13M-58.77%-10.91M424.96%3.8M267.98%10.93M-59.72%313K
Financing cash flow
Cash flow from continuing financing activities 105.16%601K-412.08%-4.57M143.40%4.27M155.59%418K119.27%484K-163.38%-11.64M201.44%1.47M-1,032.57%-9.84M-101.61%-752K-113.14%-2.51M
Net issuance payments of debt ---7.5M------------------0--0--0--0--0
Net common stock issuance --0-------------------10M----------------
Proceeds from stock option exercised by employees 312.47%8.1M99.86%2.93M2,603.16%4.27M65.87%418K443.82%484K87.23%1.96M201.44%1.47M1,655.56%158K-54.43%252K8,800.00%89K
Net other financing activities ---------------------36.97%-3.61M--10M-1,038.95%-10M-8.42%-1M-214.13%-2.6M
Cash from discontinued financing activities
Financing cash flow 105.16%601K-412.08%-4.57M143.40%4.27M155.59%418K119.27%484K-163.38%-11.64M201.44%1.47M-1,032.57%-9.84M-101.61%-752K-113.14%-2.51M
Net cash flow
Beginning cash position 73.08%56.75M-6.00%48.59M48.29%53.46M79.03%45.79M73.08%56.75M34.04%32.79M13.82%51.69M-26.14%36.05M-36.52%25.57M34.04%32.79M
Current changes in cash -167.23%-16.11M-257.38%-7.95M-131.16%-4.87M-26.72%7.68M-51.98%-10.96M187.74%23.96M140.02%5.05M560.24%15.64M22.89%10.48M-145.57%-7.21M
End cash Position -28.39%40.64M-28.39%40.64M-6.00%48.59M48.29%53.46M79.03%45.79M73.08%56.75M73.08%56.75M13.82%51.69M-26.14%36.05M-36.52%25.57M
Free cash flow 143.46%75.66M51.91%21.99M10.84%24.02M38,071.25%30.54M82.66%-893K249.81%31.08M332.00%14.48M1,694.48%21.67M-98.65%80K72.99%-5.15M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -